Rapid test for gonorrhoea and chlamydia to be developed by University of Birmingham spinout
25 November 2019: University of Birmingham spinout Linear Diagnostics Ltd has raised £2m to develop…
read moreOliver Sexton joined Midven in April 2014 to manage the UK Innovation & Science Seed Fund’s synthetic biology investments.
Prior to joining Midven, Oliver managed commercialisation of bioengineering and medical technologies At Imperial Innovations and was on the board of oncology therapeutic Acublate Ltd. Earlier in his career he held commercial and partnering roles at Ark Therapeutics.
Oliver also managed a team of biotech buy-side analysts and worked at a pharma strategy consultancy.
Oliver has a BSc in Molecular Biology/Biotechnology and an MSc in Plant Science from Bristol University.
Telephone 0121 710 1990
“Turning world-leading research into profitable companies is no simple matter, but we are now at a point where many of those technologies are suitable for broad commercial application. UK Innovation & Science Seed Fund is providing not just capital, but the expertise and the networks to maximize the chances of success in existing markets and in the new markets that synthetic biology enables.”
25 November 2019: University of Birmingham spinout Linear Diagnostics Ltd has raised £2m to develop…
read more© Giulia Spadafora / Soul Media UKI2S would like to congratulate CytoSeek on winning the…
read more14th June 2019 / UKI2S, a leading early-stage venture capital fund facilitating the growth of…
read moreAcquisition furthers Astellas’ commitment to innovation in ophthalmology with addition of novel gene therapy program…
read moreBanana plantations in Australia, south-east Asia, Africa and the Middle East have been ravaged by…
read moreSynthace London-based Synthace provides next-generation software and processes to exponentially improve productivity in bioscience, enabling…
read moreUKI2S announced in August the successful exit of its portfolio company Quethera. Acquired by Japanese…
read moreOliver Sexton, MSc, is Midven’s investment director and manager of UK Innovation & Science Seed…
read moreWhen we talk about the tech revolution that is currently sweeping the industrialised world,…
read more